Browse by author
Lookup NU author(s): Emerita Professor Helen Foster
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Novel therapies including biologic agents offer paediatric rheumatologists significant opportunity to improve long-term prognosis for children with rheumatic disease. However, comorbidities related to the diseases themselves and their treatments pose specific challenges to be overcome. Prompt recognition and appropriate management will improve quality of life, effectiveness of treatment and overall prognosis. In this review, we discuss key areas of comorbidity frequently encountered in paediatric rheumatology including cardiovascular, renal, genito-urinary and visual comorbidity, bone health, drug-related issues and the influence of rheumatic disease on growth and puberty.
Author(s): Smith EMD, Foster HE, Beresford MW
Publication type: Review
Publication status: Published
Journal: Rheumatology
Year: 2013
Volume: 52
Issue: 1
Pages: 22-33
Print publication date: 28/09/2012
ISSN (print): 1462-0324
ISSN (electronic): 1462-0332
Publisher: OXFORD UNIV PRESS
URL: http://dx.doi.org/10.1093/rheumatology/kes256
DOI: 10.1093/rheumatology/kes256